Skip to main content
. 2023 Sep 14;485(4):723–728. doi: 10.1007/s00428-023-03643-1

Fig. 2.

Fig. 2

Expression pattern in atypical intraductal lesions of the prostate. Appl1/Sortilin/Syndecan-1 and AMACR expression in HGPIN, AIP, and prostatic adenocarcinoma. Intensity was scored 0–3+, and moderate-to-high (≥ 2) expression is shown